These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 1949413)

  • 1. [Estrogenization with natural hormones in the treatment of prostatic cancer (experimental research)].
    Lopatkin NA; Gaĭbullaev AA
    Urol Nefrol (Mosk); 1991; (4):3-7. PubMed ID: 1949413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Zinc metabolism in male rats with a transplanted ovary].
    Gaĭbullaev AA; Lopatkin NA; Evseev LP; Sevriukov EA
    Biull Eksp Biol Med; 1991 Nov; 112(11):536-8. PubMed ID: 1810498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacologic basis for the enhanced efficacy of dutasteride against prostatic cancers.
    Xu Y; Dalrymple SL; Becker RE; Denmeade SR; Isaacs JT
    Clin Cancer Res; 2006 Jul; 12(13):4072-9. PubMed ID: 16818707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of coumarin on the normal rat prostate and on the R-3327H prostatic adenocarcinoma.
    Omarbasha B; Fair WR; Heston WD
    Cancer Res; 1989 Jun; 49(11):3045-9. PubMed ID: 2720665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained in vivo regression of Dunning H rat prostate cancers treated with combinations of androgen ablation and Trk tyrosine kinase inhibitors, CEP-751 (KT-6587) or CEP-701 (KT-5555).
    George DJ; Dionne CA; Jani J; Angeles T; Murakata C; Lamb J; Isaacs JT
    Cancer Res; 1999 May; 59(10):2395-401. PubMed ID: 10344749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the preestrogen 4-androstene-3,17-dion-19-al on the Dunning R3327 prostatic adenocarcinoma.
    Marks TA; Petrow V
    Cancer Res; 1983 Aug; 43(8):3687-90. PubMed ID: 6861138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of site of transplantation on follicular development of human ovarian tissue transplanted into intact or castrated immunodeficient mice.
    Hernandez-Fonseca H; Bosch P; Sirisathien S; Wininger JD; Massey JB; Brackett BG
    Fertil Steril; 2004 Mar; 81 Suppl 1():888-92. PubMed ID: 15019825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the effects of oestrogen in the male. Some effects of different oestrogenic substances in rats and men with prostatic carcinoma.
    Daehlin L
    Scand J Urol Nephrol Suppl; 1985; 91():1-44. PubMed ID: 3868029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [An experimental study of the antitumor activity of preparations in a model of prostatic cancer].
    Burenin IS; Matveev BP; Kiselev VI; Zhumagazin ZhD; Smirnova IO; Bukharkin BV
    Urol Nefrol (Mosk); 1995; (5):33-5. PubMed ID: 8571483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonist RC-3095 on the growth of the androgen-independent Dunning R-3327-AT-1 rat prostate cancer.
    Pinski J; Reile H; Halmos G; Groot K; Schally AV
    Cancer Res; 1994 Jan; 54(1):169-74. PubMed ID: 7903203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogens in the treatment of prostate cancer.
    Cox RL; Crawford ED
    J Urol; 1995 Dec; 154(6):1991-8. PubMed ID: 7500443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The synergistic effect of sustained delivery of DHT, DHEA, and E on the ventral prostate of adult male rodents.
    Cavett W; Cason Z; Tucci M; Puckett A; Benghuzzi H
    Biomed Sci Instrum; 1997; 34():30-5. PubMed ID: 9603008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized comparison of total androgen blockade alone versus combined with weekly epirubicin in advanced prostate cancer.
    Pummer K; Lehnert M; Stettner H; Hubmer G
    Eur Urol; 1997; 32 Suppl 3():81-5. PubMed ID: 9267791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histopathological evidence for an association of inflammation with ductal pin-like lesions but not with ductal adenocarcinoma in the prostate of the noble rat.
    Bernoulli J; Yatkin E; Laakso A; Anttinen M; Bosland M; Vega K; Kallajoki M; Santti R; Pylkkänen L
    Prostate; 2008 May; 68(7):728-39. PubMed ID: 18302197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prostate cancer].
    Kawai T; Washizuka M; Takahashi T; Kusuyama H
    Gan To Kagaku Ryoho; 1984 May; 11(5):999-1004. PubMed ID: 6202247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocellular neoplasms after intrahepatic transplantation of ovarian fragments into ovariectomized rats.
    Dombrowski F; Flaschka C; Klotz L; von Netzer B; Schulz C; Lehnert H; Evert M
    Hepatology; 2006 Apr; 43(4):857-67. PubMed ID: 16557532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocrine treatment of prostate cancer.
    Tammela T
    J Steroid Biochem Mol Biol; 2004 Nov; 92(4):287-95. PubMed ID: 15663992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rat prostatic weight regression in reaction to ketoconazole, cyproterone acetate, and RU 23908 as adjuncts to a depot formulation of gonadotropin-releasing hormone analogue.
    Lamberts SW; Uitterlinden P; de Jong FH
    Cancer Res; 1988 Nov; 48(21):6063-8. PubMed ID: 2844399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentiation of the antiangiogenic ability of linomide by androgen ablation involves down-regulation of vascular endothelial growth factor in human androgen-responsive prostatic cancers.
    Joseph IB; Isaacs JT
    Cancer Res; 1997 Mar; 57(6):1054-7. PubMed ID: 9067270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-targeted apoptosis by a novel spermine analogue, 1,12-diaziridinyl-4,9-diazadodecane, results in therapeutic efficacy and enhanced radiosensitivity of human prostate cancer.
    Eiseman JL; Rogers FA; Guo Y; Kauffman J; Sentz DL; Klinger MF; Callery PS; Kyprianou N
    Cancer Res; 1998 Nov; 58(21):4864-70. PubMed ID: 9809992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.